Targeting the human β c receptor inhibits inflammatory myeloid cells and lung injury caused by acute cigarette smoke exposure.

Nok Him FungHao WangRoss VlahosNick WilsonAngel F LopezCatherine M OwczarekSteven Bozinovski

Published in: Respirology (Carlton, Vic.) (2022)

This study identifies CSL311 as a therapeutic antibody that potently inhibits immunopathology and lung injury caused by acute CS exposure.

Keyphrases